IP Library Granted Patent US 9,078,829
Granted Patent B2
US 9,078,829 · App. 14/485,793 · Granted Jul 14, 2015

Compositions and method for hair loss prevention

Inventor: Giuseppe Trigiante (Watford, GB)
Assignee: Yagna Limited
A61K8/4953A61K8/27A61K8/33A61K8/35A61K8/361A61K8/362A61K8/37A61K8/4926A61K8/4946A61K8/58A61K8/97A61K9/0014A61K9/08A61K31/435A61K31/496A61K31/505A61K31/555A61K33/04A61K36/61A61K45/06A61Q5/006A61Q7/00A61Q17/005A61K2800/49
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,078,829
App. No.
14/485,793
Granted
Jul 14, 2015
Kind
B2
Abstract

The invention encompasses a formulation for hair loss prevention comprising a mixture of water and at least one nonpolar aprotic organic solvent and at least one hair loss preventive ingredient known to inhibit the hormonal mechanism underlying androgenetic hair loss and methods of using the same.

Claims (16)

1. A method of treating hair loss comprising applying a hair loss treating formulation in a therapeutically sufficient amount to an area of skin, wherein the formulation comprises at least one hair loss treating ingredient known to inhibit the hormonal mechanism underlying androgentic hair loss, a C 6 -C 14 dicarboxylic acid, and a mixture of water and at least one aprotic organic solvent, wherein the mixture of water and aprotic organic solvent is capable of solubilizing sebum and allowing the at least one ingredient to reach the skin and/or hair follicle, and wherein the aprotic organic solvent is present in an amount of 60% to 90% by weight of the formulation and the water is present in an amount of 2% to 20% by weight of the formulation.

2. The method according to claim 1 , wherein the at least one aprotic organic solvent is selected from the group consisting of esters, aldehydes, ketones and mixtures thereof.

3. The method according to claim 2 , wherein the ester is methyl formate, ethyl formate, propyl formate, methyl acetate, ethyl acetate, propyl acetate, methyl propionate, ethyl propionate or propyl prionate.

4. The method according to claim 2 , wherein the aldehyde is acetaldehyde, propionaldehyde, or butyraldehyde.

5. The method according to claim 2 , wherein the ketone is acetone, butanone, pentanone, ethylisopropyl ketone, or methylisobutyl ketone.

6. The method according, to claim 2 , wherein the at least one aprotic organic solvent is C 2 -C 6 ester, C 2 -C 4 aldehyde, or a C 3 -C 6 ketone.

7. The method according to claim 1 , wherein the C 6 -C 14 dicarboxylic acid is pimelic acid, suberic acid, azelaic acid, sebacic acid, undecanedioic acid, dodecanedioic acid or brassylic acid.

8. The method according to claim 7 , wherein the C 4 -C 14 dicarboxylic acid is azelaic acid.

9. The method according to claim 1 , wherein the C 6 -C 14 dicarboxylic acid is present in an amount of about 2% to 30% by weight of the formulation.

10. The method according to claim 1 , wherein the formulation further comprises a herbal extract.

11. The method according to claim 1 , wherein the formulation further comprises at least one antifungal compound.

12. The method according to claim 11 , wherein the at least one antifungal compound is zinc pyrithione, tar, selenium sulphide, ketoconazole, or tea tree oil.

13. The method according to claim 1 , wherein the formulation further comprises finasteride, minoxidil, tretinoin or combinations thereof.

14. The method according to claim 13 , wherein the finasteride, minoxidil, or tretinoin is present in an amount of about 0.001% to 5% by weight of the formulation.

15. The method according to claim 1 , wherein the formulation further comprises minoxidil.

16. The method according to claim 1 , wherein said formulation comprises acetone at 76% by weight of the formulation, azelaic acid at 17% by weight of the formulation, zinc pyrithione at 0.05% by weight of the formulation, minoxidil at 2% by weight of the formulation and finasteride at 0.2% by weight of the formulation.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 6, 2015
From: YAGNA LIMITED
To: HUMANITARIAN SCIENTIFIC LLC
Reel/Frame 036734/0239 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2015
From: TRIGIANTE, GIUSEPPE
To: YAGNA LIMITED
Reel/Frame 036475/0898 →
Continuity (3)
Division 11977859 · Oct 26, 2007
Provisional Application 60854810 · Oct 27, 2006
Related Publication 20140377384A1 · Dec 25, 2014